We are live on ! Find out more
BRTX icon

BioRestorative Therapies

11 hedge funds and large institutions have $1.72M invested in BioRestorative Therapies in 2021 Q4 according to their latest regulatory filings, with 11 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

11.37% more ownership

Funds ownership: 0%11.37% (+11%)

Holders
11
Holders Change
+11
Holders Change %
% of All Funds
0.17%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
11
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$662K +$871K +152,454 New
AC
2
Ayrton Capital
Connecticut
$489K +$644K +112,762 New
BFM
3
Boothbay Fund Management
New York
$278K +$365K +63,984 New
WA
4
Wealth Alliance
New York
$174K +$228K +40,000 New
SG
5
StoneX Group
New York
$64.9K +$85.4K +14,954 New
SM
6
Sabby Management
Florida
$43K +$57.1K +10,000 New
SPIA
7
Steward Partners Investment Advisory
New York
$9K +$11.4K +2,001 New
Osaic Holdings
8
Osaic Holdings
Arizona
$1K +$1.11K +194 New
UBS Group
9
UBS Group
Switzerland
$1K +$1.74K +304 New
JWM
10
Janiczek Wealth Management
Colorado
+$6 +1 New
Wells Fargo
11
Wells Fargo
California
+$80 +14 New

BRTX Hedge Fund Activity: Q4 2021 in Review

11 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in BioRestorative Therapies (BRTX) for Q4 2021, worth a combined $1.72M.

Buyers outnumbered sellers: 11 funds opened new BRTX positions and 0 closed out — a net gain of 11 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Vanguard Group, opening a new position worth an estimated $871K.

  • 11 institutional investors held BioRestorative Therapies (BRTX) as of Q4 2021, up from 0 in Q3 2021.
  • Funds reported $1.72M of BioRestorative Therapies stock for Q4 2021.
  • 11 funds opened new BioRestorative Therapies positions in Q4 2021 and 0 closed out, a net change of +11 holders.
  • The largest BioRestorative Therapies buyer in Q4 2021 was Vanguard Group, an estimated $871K added.

Based on aggregated 13F filings for Q4 2021.